A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis.
Rice TW, Wheeler AP, Bernard GR, Vincent JL, Angus DC, Aikawa N, Demeyer I, Sainati S, Amlot N, Cao C, Ii M, Matsuda H, Mouri K, Cohen J.
Rice TW, et al. Among authors: bernard gr.
Crit Care Med. 2010 Aug;38(8):1685-94. doi: 10.1097/CCM.0b013e3181e7c5c9.
Crit Care Med. 2010.
PMID: 20562702
Clinical Trial.